Roughly 1 in 3 adults has metabolic dysfunction–associated steatotic liver disease, or MASLD. A doctor outlines how to detect ...

ENDRA Life Sciences Inc. (NASDAQ: NDRA) ("ENDRA" or the "Company"), a pioneer in biomarker imaging technologies for the early ...

An investigational multi-target blood test was three times more sensitive than standard ultrasound surveillance for detecting ...

Fatty liver disease is becoming increasingly common, affecting millions around the world. The underlying cause of this is too ...

Rezdiffra® treatment significantly improved liver stiffness, fibrosis biomarkers, and markers of clinically significant portal hypertension risk ...

Recognizing early liver disease signs is crucial as many conditions develop silently. Persistent fatigue, jaundice, abdominal swelling, confusion, fre ...

Dr. Christopher Kelly: A biomarker is a biological substance that can be objectively measured and tracked to provide ...

Detailed price information for Exact Sciences Cor (EXAS-Q) from The Globe and Mail including charting and trades.

The retrospective phase 2b study, which explored the use of various non-invasive tests (NITs) to assess response to semaglutide, adds to growing evidence that the drug not only improves metabolic ...

Given just how much lifestyle disorders or non-communicable diseases are on the rise these days, it is quite likely that you would have taken a liver function test (LFT) and then consulted the doctor ...

Liver fibrosis is a growing global concern, driven by chronic conditions like hepatitis, obesity, and alcohol use. This progressive liver disease, marked by scar tissue buildup, can advance to ...

At the American Association for the Study of Liver Diseases (AASLD) annual meeting, a session highlighted new guidance on ...